Alkermes (ALKS) Price to FCF (2010 - 2026)
Alkermes' (ALKS) quarterly Price to FCF came in at 64.06 in Q2 2026, up 86.11% year-over-year from 34.42 in Q2 2025, and up 284.85% quarter-over-quarter from 34.66 in Q1 2026.
Analysis
Alkermes (ALKS) Price to FCF (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Price to FCF for 17 consecutive years, with 64.06 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Price to FCF rose 86.11% year-over-year to 64.06 in Q2 2026; TTM through Jun 2026 was 39.61, a 302.47% increase from a year earlier, with the FY2025 full-year figure at 9.65, down 16.1% from the prior year.
- Price to FCF was 64.06 for Q2 2026 at Alkermes, up from 34.66 in the prior quarter.
- Over five years, Price to FCF peaked at 358.75 in Q1 2024 and troughed at 478.25 in Q4 2022.
- A 5-year average of 16.05 and a median of 31.6 in 2025 frame the typical range for Price to FCF.
- The widest YoY moves for Price to FCF: up 649.02% in 2022, down 682.44% in 2022.
- Over 5 years, Price to FCF stood at 478.25 in 2022, then surged by 110.74% to 51.35 in 2023, then plunged by 49.71% to 25.82 in 2024, then rose by 5.5% to 27.24 in 2025, then surged by 135.16% to 64.06 in 2026.
- The last three Price to FCF figures came in at 64.06 (Q2 2026), 34.66 (Q1 2026), and 27.24 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.10 Bn | 625.34 Bn | 17.26 Bn |
| 2 | AbbVie | 441.68 Bn | 435.11 Bn | 12.70 Bn |
| 3 | Merck | 366.62 Bn | 359.48 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.55 Bn | 258.86 Bn | 11.24 Bn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn |
| 6 | Sanofi | 52.40 Bn | 45.02 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - |
| 8 | Incyte | 25.59 Bn | 21.05 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.54 Bn | 18.88 Bn | 683.80 Mn |
| 10 | Alkermes | 7.57 Bn | 6.91 Bn | 397.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 64.06 |
| Mar 31, 2026 | -34.66 |
| Dec 31, 2025 | 27.24 |
| Sep 30, 2025 | 58.72 |
| Jun 30, 2025 | 34.42 |
| Mar 31, 2025 | 61.37 |
| Dec 31, 2024 | 25.82 |
| Sep 30, 2024 | 61.75 |
| Jun 30, 2024 | 28.78 |
| Mar 31, 2024 | 358.75 |
| Dec 31, 2023 | 51.35 |
| Sep 30, 2023 | 54.77 |
| Jun 30, 2023 | 25.30 |
| Mar 31, 2023 | -166.22 |
| Dec 31, 2022 | -478.25 |
| Sep 30, 2022 | -372.51 |
| Jun 30, 2022 | -398.80 |
| Mar 31, 2022 | 309.22 |
| Dec 31, 2021 | 168.46 |
| Sep 30, 2021 | 63.96 |